Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Bowen Yang is reportedly leaving 'Saturday Night Live' after this week's episode - 2Yemen's Houthis ready to join Iran war if needed, raising new shipping risk
- 3The Delight of Perusing: Book Proposals for Each Class
- 4Are IDF reservists properly armed during post-war operations?
- 57 Odd Apparatuses to Make Your Party Stick Out!
- Vote in favor of Your #1 sort of pie
- Latvia seeks emergency UN meeting over Russian missile attack on Lviv
- Supportive Tips On Home loans For First-Time Home Purchasers
- Support Your Investment funds with These Individual accounting Thoughts
- Moderna to complete US mRNA manufacturing network with $140 million investment
- Dolly Parton misses Dollywood event due to 'a few health challenges' after skipping honorary Oscars
- Here's what can happen if you drive under the influence of pot
- January full moon wows skywatchers with a striking 'Wolf Supermoon' (photos)
- Ocean side Locations for a Family Excursion
